Rebecca Lowe. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Cerebral Hemorrhage/complicationsCerebral Hemorrhage/drug therapyClinical Trials as Topic/methodsFactor VII/therapeutic useFactor VIIaHemophilia A/drug therapyHemophilia A/etiologyHumansRecombinant Proteins/therapeutic useTreatment Outcome
Substances： See more » Recombinant ProteinsFactor VIIrecombinant FVIIaFactor VIIa
Year: 2004 PMID： 15303268 DOI： 10.1016/s1474-4422(04)00834-8
Source DB: PubMed Journal: Lancet Neurol ISSN： 1474-4422 Impact factor: 44.182